What nabilone is
Nabilone is an orally administered synthetic analogue of THC. Health Canada identifies marketed prescription nabilone products and an authorization for severe nausea and vomiting associated with cancer chemotherapy. Product identity, strength, indication, and market status are separate facts.
A standardized prescription capsule is not interchangeable with cannabis flower, extracts, or another cannabinoid medicine.
What the evidence and approval mean
Authorization supports use under the reviewed product conditions; it does not establish benefit for every symptom studied in small trials. Human trial evidence, adverse effects, interactions, and the product monograph matter more than mechanistic or animal findings for clinical decisions.
US and Canadian approvals and availability can differ. A drug being authorized does not mean it is suitable, available, or publicly covered for every person.
Access is a clinical question
Canadian readers should check the current Health Canada Drug Product Database and discuss the approved indication, contraindications, other medicines, and monitoring with a licensed prescriber or pharmacist.
This page does not recommend a dose, determine eligibility, or provide prescribing advice.